Blood Leukocyte Natural Killer Activity as an Early Diagnostic Indicator of Leukaemic Relapse

  • J. A. Tratkiewicz
  • J. Szer
  • R. L. Boyd
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 237)


Natural cell mediated immunity is a well-defined system that may play a role in cancer defence. In contrast to specific T-cell mediated immunity, the mediators of natural immunity, Natural Killer (NK) cells, appear to be non-specific and their lytic activity is not restricted by major histocompatibility (MHC) determinants1.


Natural Killer Natural Killer Cell Chronic Lymphocytic Leukemia Hairy Cell Leukemia Natural Killer Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ortaldo J.R. & Herberman R.B., Heterogeneity of natural killer cells. Annu. Rev. Immunol. 2: 359 (1984).PubMedCrossRefGoogle Scholar
  2. 2.
    Lanier L.L., Cwirla S., Federspiel N., & Phillips J.H., Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor B chain genes. J. Exp. Med. 163: 209 (1986).PubMedCrossRefGoogle Scholar
  3. 3.
    Barada FA. Jr., Kay H.D., Emmons R., Davis J.S., Horwitz DA., Natural cytotoxicity of adherent cells from human blood: role of the Fc receptor. J. Immunol. 125: 865, (1980).PubMedGoogle Scholar
  4. 4.
    Bakacs T., Gergely P., Cornain S., Klein E., Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures. Int. J. Cancer 19: 441, (1977).PubMedCrossRefGoogle Scholar
  5. 5.
    Lanier L.L., Le A.M., Phillips J.H., Warner N.L., Babcock G.F., Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu 11 (NK-15) antigens. J. Immunol. 131: 1789, (1983).PubMedGoogle Scholar
  6. 6.
    Timonen T., Ranki A., Saksela E., Hayry P., Fractionization, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cell. Immunol. 48: 121 (1979).PubMedCrossRefGoogle Scholar
  7. 7.
    Sorskaar D., Lie S.O., Forre O., Natural killer cell activity of peripheral blood and bone marrow mononuclear cells from patients with childhood acute lymphoblastic leukemia. Acta. Paediatr. Scand. 74: 433 (1985).PubMedCrossRefGoogle Scholar
  8. 8.
    Yates J., Glidewell O., Wiernik P., Cooper M.R., Steinberg D., Dosik H., Levy R., Hoagland C., Henry P., Gottlieb A., Cornell C, Berenberg J., Hutchinson J.L., Raich P., Nissen N., Ellison R.R., Frelick R., James G.W., Falkson G., Silver R.T, Haurani F., Green M., Henderson E., Leone L., Holland J.F., Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood 60: 454, (1982).PubMedGoogle Scholar
  9. 9.
    Boyum A., A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a lg gravity field. Scand. J. Clin. Lab. Invest. 21 (Suppl 97): 51, (1968).Google Scholar
  10. 10.
    Andersson L.C., Nilsson K., & Gahmberg CG., K562 — A human erythroleukemic cell line. Int. J. Cancer 23: 143 (1979).PubMedCrossRefGoogle Scholar
  11. 11.
    Brunner K.T., Engers H.D., Cerottini J.C., The 51Cr release assay as used for the quantitative measurement of cell-mediated cytolysis in vitro, in: “In vitro methods in cell-mediated and tumor immunity,” Bloom B.R, David J.R, eds., Academic Press, New York (1976).Google Scholar
  12. 12.
    Dickinson A., Proctor S.J., Jacobs E., Reed M.M., Walker W., Craft A.W., Kernahan J., Natural killer cell activity in childhood acute lymphoblastic leukaemia in remission. Br. J. Haematol. 59: 45 (1985).PubMedCrossRefGoogle Scholar
  13. 13.
    Kay N.E, Zarling J.M., Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells. Blood 63: 305, (1984).PubMedGoogle Scholar
  14. 14.
    Ruco L.P, Procopio A., Maccallini V., Calogero A., Uccini S., Annino C, Mandelli F., Baroni C.D.: Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 61: 1132 (1983).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • J. A. Tratkiewicz
    • 1
  • J. Szer
    • 1
  • R. L. Boyd
    • 1
  1. 1.Alfred Hospital & Monash UniversityPrahranAustralia

Personalised recommendations